Unexpected Demand for ActHIB Causes Shortage of Supply

March 16, 2009
Daiichi Sankyo (distributor) and Sanofi Pasteur (manufacturer) began negotiations with the aim of increasing the production and import of ActHIB, a pediatric vaccine against Haemophilus influenzae type-b (Hib) that causes bacterial meningitis in children and infants aged less than two...read more